EDG-15400 for Heart Failure
(EQUINOX Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a Phase 2 placebo-controlled study to evaluate the safety and tolerability of different doses of EDG-15400 in adults with heart failure with preserved ejection fraction (HFpEF).
Are You a Good Fit for This Trial?
This trial is for adults diagnosed with heart failure with preserved ejection fraction (HFpEF). Participants should meet specific medical criteria related to their heart condition. People with other major health issues or who don't fit the study's requirements cannot join.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study is testing two different doses of a new drug called EDG-15400 compared to a placebo (inactive pill) in people with HFpEF, to see how safe and tolerable the drug is. Participants are randomly assigned to one of the groups.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Edgewise Therapeutics, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.